Literature DB >> 24890834

Cell therapy in dermatology.

Gabriela Petrof1, Alya Abdul-Wahab1, John A McGrath1.   

Abstract

Harnessing the regenerative capacity of keratinocytes and fibroblasts from human skin has created new opportunities to develop cell-based therapies for patients. Cultured cells and bioengineered skin products are being used to treat patients with inherited and acquired skin disorders associated with defective skin, and further clinical trials of new products are in progress. The capacity of extracutaneous sources of cells such as bone marrow is also being investigated for its plasticity in regenerating skin, and new strategies, such as the derivation of inducible pluripotent stem cells, also hold great promise for future cell therapies in dermatology. This article reviews some of the preclinical and clinical studies and future directions relating to cell therapy in dermatology, particularly for inherited skin diseases associated with fragile skin and poor wound healing.
Copyright © 2014 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh：

Year:  2014        PMID： 24890834      PMCID： PMC4031958          DOI： 10.1101/cshperspect.a015156

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN： 2157-1422            Impact factor:   6.915


  131 in total

1.  A multicenter, double-blind, placebo-controlled trial of autologous fibroblast therapy for the treatment of nasolabial fold wrinkles.

Authors:  Stacy R Smith; Girish Munavalli; Robert Weiss; John M Maslowski; Kevin P Hennegan; Jeanne M Novak
Journal:  Dermatol Surg       Date:  2012-03-12       Impact factor: 3.398

2.  A mouse model of generalized non-Herlitz junctional epidermolysis bullosa.

Authors:  Jason A Bubier; Thomas J Sproule; Lydia M Alley; Cameron M Webb; Jo-David Fine; Derry C Roopenian; John P Sundberg
Journal:  J Invest Dermatol       Date:  2010-03-25       Impact factor: 8.551

3.  Type VII collagen gene expression by cultured human cells and in fetal skin. Abundant mRNA and protein levels in epidermal keratinocytes.

Authors:  J Ryynänen; S Sollberg; M G Parente; L C Chung; A M Christiano; J Uitto
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

4.  A randomized trial comparing ReCell system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns.

Authors:  G Gravante; M C Di Fede; A Araco; M Grimaldi; B De Angelis; A Arpino; V Cervelli; A Montone
Journal:  Burns       Date:  2007-09-29       Impact factor: 2.744

5.  A homogeneous cell-based bicistronic fluorescence assay for high-throughput identification of drugs that perturb viral gene recoding and read-through of nonsense stop codons.

Authors:  Tony S Cardno; Elizabeth S Poole; Suneeth F Mathew; Ryan Graves; Warren P Tate
Journal:  RNA       Date:  2009-06-17       Impact factor: 4.942

6.  Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity.

Authors:  Johannes S Kern; Stefan Loeckermann; Anja Fritsch; Ingrid Hausser; Wera Roth; Thomas M Magin; Claudia Mack; Marcel L Müller; Oliver Paul; Patrick Ruther; Leena Bruckner-Tuderman
Journal:  Mol Ther       Date:  2009-06-30       Impact factor: 11.454

7.  HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa.

Authors:  Nikoletta Nagy; Noor Almaani; Akio Tanaka; Joey E Lai-Cheong; Tanasit Techanukul; Jemima E Mellerio; John A McGrath
Journal:  J Invest Dermatol       Date:  2011-04-07       Impact factor: 8.551

8.  The use of cultured epithelial autograft in the treatment of major burn wounds: eleven years of clinical experience.

Authors:  F M Wood; M L Kolybaba; P Allen
Journal:  Burns       Date:  2006-06-14       Impact factor: 2.744

9.  Treatment of chronic erosions of junctional epidermolysis bullosa with human epidermal allografts.

Authors:  J C Hill; R E Grimwood; D S Parsons
Journal:  J Dermatol Surg Oncol       Date:  1992-05

10.  Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.

Authors:  David T Woodley; Gerald G Krueger; Cynthia M Jorgensen; Janet A Fairley; Tom Atha; Yi Huang; Lawrence Chan; Douglas R Keene; Mei Chen
Journal:  J Invest Dermatol       Date:  2003-11       Impact factor: 8.551
View more
  7 in total

Review 1.  Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat Wounds.

Authors:  Alex du Rand; John M T Hunt; Vaughan Feisst; Hilary M Sheppard
Journal:  Mol Diagn Ther       Date:  2022-10-17       Impact factor: 4.476

2.  Cryomicroneedles for transdermal cell delivery.

Authors:  Hao Chang; Sharon W T Chew; Mengjia Zheng; Daniel Chin Shiuan Lio; Christian Wiraja; Yu Mei; Xiaoyu Ning; Mingyue Cui; Aung Than; Peng Shi; Dongan Wang; Kanyi Pu; Peng Chen; Haiyan Liu; Chenjie Xu
Journal:  Nat Biomed Eng       Date:  2021-05-03       Impact factor: 25.671

Review 3.  Cellular Therapies in Systemic Sclerosis: Recent Progress.

Authors:  Femke C C van Rhijn-Brouwer; Hendrik Gremmels; Joost O Fledderus; Timothy R D Radstake; Marianne C Verhaar; Jacob M van Laar
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

Review 4.  Current and Future Perspectives of Stem Cell Therapy in Dermatology.

Authors:  Christine M Prodinger; Julia Reichelt; Johann W Bauer; Martin Laimer
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444

5.  Corneal stromal stem cells reduce corneal scarring by mediating neutrophil infiltration after wounding.

Authors:  Andrew J Hertsenberg; Golnar Shojaati; Martha L Funderburgh; Mary M Mann; Yiqin Du; James L Funderburgh
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

Review 6.  Skin tissue regeneration for burn injury.

Authors:  Anastasia Shpichka; Denis Butnaru; Evgeny A Bezrukov; Roman B Sukhanov; Anthony Atala; Vitaliy Burdukovskii; Yuanyuan Zhang; Peter Timashev
Journal:  Stem Cell Res Ther       Date:  2019-03-15       Impact factor: 6.832

7.  Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells.

Authors:  Mandana Veiseh; Sean J Leith; Cornelia Tolg; Sallie S Elhayek; S Bahram Bahrami; Lisa Collis; Sara Hamilton; James B McCarthy; Mina J Bissell; Eva Turley
Journal:  Front Cell Dev Biol       Date:  2015-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.